About
Here is a polished organisation-page description:
Qlarix is a clinical technology company focused on helping sponsors and clinical research organisations apply Risk-Based Quality Management in a practical, structured and proportionate way.
Our flagship solution, WiseCLIN, brings the key elements of RBQM into one connected workflow, including Critical-to-Quality factors, risk identification and evaluation, control actions, KRIs, QTLs, risk reviews, decisions and oversight evidence. By replacing fragmented spreadsheets, documents and disconnected systems, WiseCLIN gives clinical teams a clearer view of study risks and helps them focus their attention where it matters most.
Qlarix was founded by experienced clinical quality professionals with a strong understanding of GCP, sponsor oversight and the operational challenges faced by clinical trial teams. Our approach combines regulatory expertise with technology to support consistent decision-making, stronger oversight and greater inspection readiness.
WiseCLIN is designed to support the principles of ICH E6(R3) and to make RBQM more accessible to organisations of different sizes, from emerging biotechnology companies to larger sponsors and CROs.
At Qlarix, we believe that effective quality management is not about controlling everything. It is about identifying what is critical, understanding the risks and knowing where to act.
Sector
Pharmaceutical industryDigital health